These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26981932)

  • 1. Health Care Tax Inversions--Robbing Both Peter and Paul.
    Warraich HJ; Schulman KA
    N Engl J Med; 2016 Mar; 374(11):1005-7. PubMed ID: 26981932
    [No Abstract]   [Full Text] [Related]  

  • 2. Winners and losers. Corporate tax overhaul would have very different effects for various healthcare sectors.
    Kutscher B
    Mod Healthc; 2013 Apr; 43(15):6-7, 1. PubMed ID: 23741756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fighting back. Devicemakers, others battling taxes tied to reform.
    Rhea S
    Mod Healthc; 2009 Oct; 39(42):10-1. PubMed ID: 19877318
    [No Abstract]   [Full Text] [Related]  

  • 4. Transparency of industry payments needed in clinical practice guidelines.
    Vassar M; Bibens M; Wayant C
    BMJ Evid Based Med; 2019 Feb; 24(1):8-9. PubMed ID: 30042209
    [No Abstract]   [Full Text] [Related]  

  • 5. People & places: Sector focuses on device excise tax.
    Health Aff (Millwood); 2010 Jul; 29(7):1330. PubMed ID: 20606182
    [No Abstract]   [Full Text] [Related]  

  • 6. Are hospitals next in line? Government investigators probing relationships between physicians, devicemakers may soon train sights on hospitals.
    Taylor M
    Mod Healthc; 2006 Aug; 36(32):24-6. PubMed ID: 16958280
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug companies will have to report all payments to US doctors from March 2014.
    Roehr B
    BMJ; 2013 Feb; 346():f826. PubMed ID: 23393117
    [No Abstract]   [Full Text] [Related]  

  • 8. Vulnerability of health to market forces.
    Brezis M; Wiist WH
    Med Care; 2011 Mar; 49(3):232-9. PubMed ID: 21301368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examining the link between cash flow, market value, and research and development investment spending in the medical device industry.
    Schmutz BP; Santerre RE
    Health Econ; 2013 Feb; 22(2):157-67. PubMed ID: 23303706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Under the influence? Study finds medical schools taking industry cash.
    Rhea S
    Mod Healthc; 2007 Oct; 37(42):14-5. PubMed ID: 18027477
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmaceuticals and medical devices: business practices. Issue brief.
    Thomson Reuters/West
    Issue Brief Health Policy Track Serv; 2011 Jan; ():1-44. PubMed ID: 21374840
    [No Abstract]   [Full Text] [Related]  

  • 12. Commentary on payment and reimbursement issues affecting the marketing of drugs, medical devices, and biologics, with emphasis on the anti-kickback statute and Stark II.
    Reiss JB
    Food Drug Law J; 1997; 52(1):99-108. PubMed ID: 10346713
    [No Abstract]   [Full Text] [Related]  

  • 13. Pricing in the Market for Anticancer Drugs.
    Howard DH; Bach PB; Berndt ER; Conti RM
    J Econ Perspect; 2015; 29(1):139-62. PubMed ID: 28441702
    [No Abstract]   [Full Text] [Related]  

  • 14. The Sunshine Act--effects on physicians.
    Agrawal S; Brennan N; Budetti P
    N Engl J Med; 2013 May; 368(22):2054-7. PubMed ID: 23718163
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmaceuticals and medical devices: business practices.
    Steiner DJ
    Issue Brief Health Policy Track Serv; 2013 Dec; ():1-36. PubMed ID: 24482889
    [No Abstract]   [Full Text] [Related]  

  • 16. The deepening crisis in U.S. health care: a review of data.
    Hellander I
    Int J Health Serv; 2011; 41(3):575-86. PubMed ID: 21842579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Sunshine Act: it's for real now.
    Katayama AC
    WMJ; 2013 Apr; 112(2):96-7. PubMed ID: 23758019
    [No Abstract]   [Full Text] [Related]  

  • 18. Comment on "Alternative Medicare financing sources".
    Aaron HJ
    Milbank Mem Fund Q Health Soc; 1984; 62(2):349-55. PubMed ID: 6425723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boom vs. bust.
    Serb C
    Hosp Health Netw; 1999 Mar; 73(3):58-9, 2. PubMed ID: 10191735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Private providers will not be exempt from corporation tax, Monitor confirms.
    Kmietowicz Z
    BMJ; 2013 Jan; 346():f326. PubMed ID: 23325881
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.